PRESS RELEASE published on 09/04/2023 at 18:20, 1 year 8 months ago EQS-Adhoc: GN Store Nord A/S: GN moves to “one company” governance structure; appoints Peter Karlstromer to Group CEO
PRESS RELEASE published on 08/16/2023 at 19:34, 1 year 9 months ago EQS-Adhoc: GN Store Nord A/S: Update of financial guidance for 2023
PRESS RELEASE published on 06/28/2023 at 22:28, 1 year 11 months ago EQS-Adhoc: GN Store Nord A/S: GN announces divestment of BelAudição
PRESS RELEASE published on 05/25/2023 at 10:59, 2 years ago EQS-Adhoc: GN Store Nord A/S announces successful completion of directed issue and private placing of new shares and existing treasury shares, raising gross proceeds of approximately DKK 2.75 bn
PRESS RELEASE published on 05/24/2023 at 17:42, 2 years ago EQS-Adhoc: GN Store Nord A/S announces plan to strengthen its capital structure to execute growth opportunities including a directed issue and private placing of a total of approximately 17 million shares
PRESS RELEASE published on 04/26/2023 at 20:49, 2 years 1 month ago EQS-Adhoc: GN Store Nord A/S: GN Store Nord delivered 7% organic revenue growth driven by strong market share gains. Full year guidance upgraded
PRESS RELEASE published on 03/15/2023 at 10:14, 2 years 2 months ago EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise
PRESS RELEASE published on 02/08/2023 at 20:50, 2 years 3 months ago EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces intention to initiate a rights issue
PRESS RELEASE published on 01/26/2023 at 11:08, 2 years 4 months ago EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces changes to the Board of Directors
Published on 05/28/2025 at 22:05, 28 minutes ago FP Newspapers Inc. Results of Annual Meeting of Shareholders
Published on 05/28/2025 at 14:30, 8 hours 3 minutes ago Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing
Published on 05/28/2025 at 14:30, 8 hours 3 minutes ago Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
Published on 05/28/2025 at 14:30, 8 hours 3 minutes ago MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program
Published on 05/28/2025 at 21:40, 52 minutes ago EQS-Adhoc: Expected termination/redemption of the Trust Preferred Securities issued by IKB Funding Trust I on June 30, 2025
Published on 05/28/2025 at 20:16, 2 hours 16 minutes ago DEAG: Growth in revenue and earnings in line with plan in Q1 2025 – strong start to financial year 2025
Published on 05/28/2025 at 19:07, 3 hours 25 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/28/2025 at 18:14, 4 hours 18 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/28/2025 at 18:09, 4 hours 23 minutes ago Vonovia SE: AGM approves €1.22 dividend and appoints Michael Rüdiger and Dr Marcus Schenck to the Supervisory Board
Published on 05/28/2025 at 18:39, 3 hours 53 minutes ago Descriptif du programme de rachat d'actions - Mai 2025
Published on 05/28/2025 at 18:39, 3 hours 53 minutes ago Description of share-buyback program - May 2025
Published on 05/28/2025 at 18:34, 3 hours 58 minutes ago AXA a placé 1 milliard d’euros d’Obligations Restricted Tier 1 et 1 milliard d’euros d’Obligations Tier 2
Published on 05/28/2025 at 18:34, 3 hours 58 minutes ago AXA announces the placement of Euro 1 billion Restricted Tier 1 Notes and Euro 1 billion Tier 2 Notes
